Stenocare
Stenocare · page 2
- Press releases
Stenocare to Launch ‘Innovative’ Astrum Oil in Germany
STENOCARE A/S (Stenocare) and ADREXpharma are now ready to deliver a new and innovative medical cannabis oil product for German patients, that has the potential to revolutionize the market.
- Press releases
Denmark’s Stenocare Announces Expansion Into Canada
STENOCARE A/S (“Stenocare”), one of Europe’s Leading Medical Cannabis pharma companies is expanding into Canada together with North American Industry experts to lead its expansion efforts.
- Companies
Stenocare Unveils Innovative Cannabis Oil with Enhanced Bioavailability
Danish medical cannabis manufacturer Stenocare has launched a new ‘next generation’ cannabis oil, which it hopes will represent the ‘next milestone in product quality and innovation’ in the space.
- Markets & Stocks
Northern Leaf Announces Merger With Voyager Life, & Stenocare Stocks Spike on Australian Expansion
Voyager Life & Northern Leaf Aquis Stock Exchange-listed CBD company Voyager Life has announced plans for a merger with Jersey-based medical cannabis cultivator Northern Leaf.
- Markets & Stocks
Ananda Announces ‘Drug Supply Agreement’, Stenocare Launches 3rd Oil in Denmark, & German Stocks React to CanG Progress
Ananda Developments Ananda Developments has seen its stock increase over 5% this week after signing a ‘Drug Supply Agreement’ (DSA) with the University of Edinburgh (UOE) and NHS Lothian.
- Opinion
What’s in Store for the European Cannabis Industry in 2024 – Part 2
2024 is set to be the year of elections, with more than half of the global population (4.2m people) set to vote in over 70 elections around the world.
- Markets & Stocks
Jazz Pharma’s Epidiolex Approved in Canada, Apollon Nears Take Over Deal, & Stenocare Expands in Australia
Jazz Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”JAZZ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Epidiolex (Epidyolex in the EU and UK), Jazz Pharmaceuticals’ market leading cannabis-based medication, has received authorisation to be prescribed for a number of conditions in Canada.
- Markets & Stocks
Celadon Signs New £26m Supply Contract, Hemp & Health Turns To Medical Cannabis, While Cellular Goods & Chill Brands Partner Up
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CEL.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] This morning (November 16), AIM-listed medical cannabis operator Celadon Pharmaceuticals announced that it has signed a new ‘commercial supply agreement’ with an unnamed ‘leading European medical cannabis company’.
- Markets & Stocks
MGC Pharma & Hellenic Dynamics Both Turn to Share Consolidation as They Secure New Funding, Stenocare Celebrates ‘Milestone’ Launch into Germany
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals announced this week that it has now secured ‘binding commitments’ for US$7.9m in investment, which the company says will be enough to fund its business plan over the next 12-months.
- Data & Analysis
Denmark’s Medical Cannabis Pilot Programme Has Seen 90% Growth Over the Last Year
Denmark’s medical cannabis Pilot Programme has seen patient numbers grow by more than 90% between Q2 2022 and Q2 2023.
- Markets & Stocks
Apollon Signs New Deal To Sell Assets, New Cannabis ETF Launches After Rescheduling News, & More From Stenocare
Apollon Formularies [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”APOL.AQ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Aquis-listed Apollon Formularies has entered into another agreement to sell its ‘global assets’ after announcing that its previous deal with Global Hemp Group (GHG) had now fallen through.
- Markets & Stocks
Cannovum Cannabis AG Announces ‘Outsourcing’ Of Medical Cannabis Business & New CEO, Futura Secures FDA Approval, & Stenocare Reports Q1 Results
Cannovum Cannabis AG [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”27N.DU” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German listed cannabis operator Cannovum Cannabis AG announced this week that it now plans to ‘outsource its existing successful medical business’.
